Market Snapshot

BSE Sensex: 74935.64 0.35%
BSE 500: 33286.91 0.45%
BSE 200: 10417.85 0.46%
BSE 100: 23883.92 0.41%
BSE Mid-Cap: 42165.72 0.59%
BSE Small-Cap: 47450.5 0.38%
BANKEX: 56218.64 0.25%
BSE IT Sector: 34339.21 -0.27%
Nifty 50: 22727.8 0.37%
Nifty 500: 21084.85 0.44%
Nifty 200: 12731.4 0.44%
Nifty 100: 23549.7 0.45%
Nifty Midcap 100: 51037.95 0.40%
Nifty Small 100: 17030.45 0.07%
Nifty IT: 33465.3 -0.34%
Nifty PSU Bank: 7556.15 -0.17%

News:

RVNLs JV bags contract worth R...
Vesuvius India soars after ste...
JNK India spurts on debut...
Power shares gain...
Consumer goods shares rise...

Lasa Supergenerics Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

30 Apr 2024 | 11:12 AM

25.66

0.03 (0.12%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

3.59%

Return (1Y)

Underperformed S&P BSE Sensex by 18.11%
More Volatile

3.42%

Standard Deviation (1Y)

Higher than S&P BSE Sensex by 2.79%
Not so consistent

6/12

Months

underperformed S&P BSE Sensex
AxisDirect View

No View

52 Week High-Low

News & Announcements

Lasa Supergenerics reports standalone net loss of Rs 1.46 crore in the December 2023 quarter
76 days ago

Lasa Supergenerics reports standalone net loss of Rs 1.46 crore in the December 2023 quarter

14 - Feb - 2024 12:00 AM | 76 days ago

Net Loss of Lasa Supergenerics reported to Rs 1.46 crore in the quarter ended December 2023 as against net loss of Rs 4.92 crore during the previous quarter ended December 2022. Sales declined 15.90% to Rs 26.66 crore in the quarter ended December 2023 as against Rs 31.70 crore during the previous quarter ended December 2022.
Particulars Quarter Ended
Dec. 2023 Dec. 2022 % Var.
Sales 26.66 31.70 -16
OPM % 3.94 -7.76 -
PBDT 0.61 -2.03 LP
PBT -2.07 -5.12 60
NP -1.46 -4.92 70
Powered by Capital Market - Live News
Lasa Supergenerics schedules board meeting
83 days ago

Lasa Supergenerics schedules board meeting

06 - Feb - 2024 12:00 AM | 83 days ago

Lasa Supergenerics will hold a meeting of the Board of Directors of the Company on 13 February 2024.
Powered by Capital Market - Live News
Lasa Supergenerics Ltd leads losers in 'B' group
123 days ago

Lasa Supergenerics Ltd leads losers in 'B' group

28 - Dec - 2023 12:00 AM | 123 days ago

Creative Eye Ltd, AksharChem (India) Ltd, STEL Holdings Ltd and Global Vectra Helicorp Ltd are among the other losers in the BSE's 'B' group today, 28 December 2023.
Lasa Supergenerics Ltd crashed 7.98% to Rs 30.34 at 14:33 IST.The stock was the biggest loser in the BSE's 'B' group.On the BSE, 1.47 lakh shares were traded on the counter so far as against the average daily volumes of 40324 shares in the past one month.
Creative Eye Ltd lost 6.82% to Rs 4.1. The stock was the second biggest loser in 'B' group.On the BSE, 1341 shares were traded on the counter so far as against the average daily volumes of 8033 shares in the past one month.
AksharChem (India) Ltd tumbled 6.71% to Rs 299.85. The stock was the third biggest loser in 'B' group.On the BSE, 14147 shares were traded on the counter so far as against the average daily volumes of 4056 shares in the past one month.
STEL Holdings Ltd plummeted 5.19% to Rs 314. The stock was the fourth biggest loser in 'B' group.On the BSE, 2020 shares were traded on the counter so far as against the average daily volumes of 3280 shares in the past one month.
Global Vectra Helicorp Ltd pared 5.15% to Rs 126. The stock was the fifth biggest loser in 'B' group.On the BSE, 1.01 lakh shares were traded on the counter so far as against the average daily volumes of 23719 shares in the past one month.
Powered by Capital Market - Live News
Lasa Supergenerics reports standalone net loss of Rs 0.02 crore in the September 2023 quarter
171 days ago

Lasa Supergenerics reports standalone net loss of Rs 0.02 crore in the September 2023 quarter

11 - Nov - 2023 12:00 AM | 171 days ago

Net Loss of Lasa Supergenerics reported to Rs 0.02 crore in the quarter ended September 2023 as against net loss of Rs 6.61 crore during the previous quarter ended September 2022. Sales declined 27.81% to Rs 24.30 crore in the quarter ended September 2023 as against Rs 33.66 crore during the previous quarter ended September 2022.
Particulars Quarter Ended
Sep. 2023 Sep. 2022 % Var.
Sales 24.30 33.66 -28
OPM % 4.32 -1.04 -
PBDT 0.57 -1.19 LP
PBT -2.11 -4.28 51
NP -0.02 -6.61 100
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Lasa Supergenerics Ltd has increased by 938.66% since past 3 Months
Lasa Supergenerics Ltd has the Lowesr P/E ratio according to FY 202303 data among stocks in Pharmaceuticals Sector
Lasa Supergenerics Ltd has the Lowesr P/B ratio according to FY 202303 data among stocks in Pharmaceuticals Sector

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2023	Dec. 2022	% Var.
Sales	26.66	31.70	-16
OPM %	3.94	-7.76	-
PBDT	0.61	-2.03	LP
PBT	-2.07	-5.12	60
NP	-1.46	-4.92	70

Particulars	Quarter Ended
	Sep. 2023	Sep. 2022	% Var.
Sales	24.30	33.66	-28
OPM %	4.32	-1.04	-
PBDT	0.57	-1.19	LP
PBT	-2.11	-4.28	51
NP	-0.02	-6.61	100

General Notifications

My Notifications

Research Notifications

Lasa Supergenerics Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

25.66 0.03 (0.12%)

News & Announcements

Price vs Volume

Stock Trivia

Lasa Supergenerics Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

25.66

0.03 (0.12%)